Atlas Trials

Mirtazapine for the Treatment of Methamphetamine Dependence Among MSM (M2.0)

Clinical trial NCT01888835 · COMPLETED

Trial details

NCT number
NCT01888835
Sponsor
Phillip Coffin, MD, MIA
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Amphetamine-Related Disorders
Start date
2013-08-01
Primary completion
2017-10-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.